Prosus N.V. (AMS:PRX)
Netherlands · Delayed Price · Currency is EUR 48.39
-1.85 (-3.68%)
Aug 1, 2025, 5:35 PM CET
Intra-Cellular Therapies Market Cap
Prosus has a market cap or net worth of €107.83 billion as of August 1, 2025. Its market cap has increased by 37.54% in one year.
Market Cap
107.83B
Enterprise Value
105.71B
Revenue
5.71B
Ranking
n/a
PE Ratio
10.14
Stock Price
$48.39
Market Cap Chart
Since September 11, 2019, Prosus's market cap has decreased from 120.56B to 107.83B, a decrease of -10.55%. That is a compound annual growth rate of -1.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 107.83B | 19.06% |
| Dec 31, 2024 | 90.57B | 31.49% |
| Dec 29, 2023 | 68.88B | -18.90% |
| Dec 30, 2022 | 84.93B | -19.22% |
| Dec 31, 2021 | 105.13B | -26.62% |
| Dec 31, 2020 | 143.28B | 32.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Universal Music Group N.V. | 44.92B |
| Koninklijke KPN N.V. | 13.63B |
| VEON Ltd. | 2.13B |
| AFC Ajax NV | 180.77M |
| ASML Holding N.V. | 270.60B |
| Unilever PLC | 136.30B |
| RELX PLC | 80.98B |
| ING Groep N.V. | 46.23B |